Clinical Research Sites Invest in Next Wave of Cloud-based Solutions

The number of clinical trials has skyrocketed over the past decade. The associated costs of drug development (and risk), continue to increase. This trend...

Investigators Matter!

TrialSite News covers news, reports and happenings involving clinical trials, investigative sites and investigators worldwide. We identify, track, and monitor investigators worldwide. The company’s...

The Industry Protocol Deviation Problem

Biopharmaceutical sponsors are squandering hundreds of millions per year on protocol deviations. The reality: increasing numbers of protocol deviations possibly convert to lower quality...
Canada Research Sites

SiteWatch Leading: LMC Manna Research the Leading Research Site Network in Canada

Based in Toronto, Canada, LMC Manna Research represents the largest network of fully-owned and integrated clinical research sites in Canada providing Phase I-IV clinical...

From Traditional IT Consultancy to Aspiring AI-Driven Clinical Data Cheetah: Saama

Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The...

Zulresso and Its’ IP Building Blocks

Thus far in 2019, four new drugs have been approved by the FDA.  TrialSite News research staff have embarked on a project to study...

Zulresso and the Social Determinants of Health Dynamics of America

  Zulresso (brexanolone) was recently approved as the first drug to treat post-partum depression (PPD). It is a medication, and naturally produced steroid that affects...
Funding

TriNetX Raises over $100 Million and Showing Up in More Discussions

TriNetX just recently raised another $40 million. The Cambridge, MA-based venture’s newest investors include Merck Global Health Innovation Fund, Mitsui & Co., Ltd., ITOCHU...

The ADAPTABLE Trial: RWD in Action by Using Electronic Health Records & PROs

Known as the Aspirin Study—A Patient-Centered Trial, it showcases use of Real-World Data (RWD) in clinical research.  A demonstration project of PCORnet (The National...

The Race to Commercialize a NASH Treatment Requires Money, Execution, and Results

France-based biotech venture Genfit S.A. (OTCPK: GNFTF) recently filed a preliminary prospectus for an initial public offering (IPO) of 5 million American Depository Shares...